"Screening for oral cancer"
is redistributed by University
of Bonn, Medical Center
Screening for oral cancer
208/04725
Get this document via a secure connection
- Summary Of Evidence
- Significance
- Evidence Of Benefit
CancerMail from the National Cancer Institute
###########################################################################
!!! ATTENTION !!!
-
The National Cancer Institute (NCI) has updated its cancer information
delivery services. In the future, please use the Cancer.gov web site
(Http: //cancer.gov/) to meet your cancer information needs. CancerMail
users in the United States can obtain cancer information by telephone at
1-800-4-CANCER (1-800-422-6237).
The NCI will no longer support CancerMail after November 2002. If you
have comments about the NCI's cancer information delivery services, contact
us by e-mail at cancer.govstaff@mail.nih.gov or call 301-496-9096.
###########################################################################
This information is intended mainly for use by doctors and other health
care professionals. If you have questions about this topic, you can ask
your doctor, or call the Cancer Information Service at 1-800-4-CANCER
(1-800-422-6237).
Information from PDQ -- for Health Professionals
Note: Separate PDQ summaries on Prevention of Oral Cancer and Lip and Oral
Cancer Treatment are also available.
There is insufficient evidence to establish that screening would result in a
decrease in mortality from oral cancer.
Level of Evidence: 5
Opinions of respected authorities based on clinical experience, descriptive
studies, or reports of expert committees.
An estimated 28,900 new cases of oral cancer are expected to be diagnosed in
the United States in 2002 and approximately 7,400 people will die of the
disease.[1] This form of cancer accounts for about 3% of cancers in men and 2%
in women.[1] It occurs more frequently in blacks than in whites.[2]
More than 90% of oral cancers occur in patients over the age of 45. The
incidence increases steadily with age until 65, when the rate levels off. Over
the last 22 years, there have been slight decreases in incidence and mortality
rates.
The primary risk factors for oral cancer in American men and women are tobacco
(including smokeless tobacco) and alcohol use. Infection with HPV-16 virus has
been associated with an excess risk of developing squamous cell carcinoma of
the oropharynx.[3]
Oral cancer occurs in a region of the body that is generally accessible to
physical examination by the patient, the dentist, and the physician. Screening
examination can be made more efficient by inspecting the high-risk sites where
90% of all oral squamous cell cancers arise: the floor of the mouth, the
ventrolateral aspect of the tongue, and the soft palate complex.[4] It has
been pointed out that high-risk individuals visit their medical doctors more
frequently than they visit their dentists. An inspection of the oral cavity is
often part of a physical examination in a dentist's or physician's office. An
oral examination often includes looking for leukoplakia and erythroplastic
lesions, that can progress to cancer.[5] Recent data suggest that molecular
markers may be useful as markers of prognosis for these pre-malignant oral
lesions. [6,7]
Although easily detected and often cured in its early stages, most oral cancers
are moderately advanced (regional stage) at the time of diagnosis.
Unfortunately, this pattern has not changed over time.
References:
- American Cancer Society: Cancer Facts and Figures-2002. Atlanta, Ga:
American Cancer Society, 2002.
-
Ries LA, Kosary CL, Hankey BF, et al., eds.: SEER Cancer Statistics
Review 1973-1995. Bethesda, Md: National Cancer Institute, 1998.
-
Mork J, Lie AK, Glattre E, et al.: Human papillomavirus infection as a
risk factor for squamous-cell carcinoma of the head and neck. New
England Journal of Medicine 344(15): 1125-1130, 2001.
-
Mashberg A, Barsa P: Screening for oral and oropharyngeal squamous
carcinomas. CA: A Cancer Journal for Clinicians 34(5): 262-268, 1984.
-
Chiodo GT, Eigner T, Rosenstein DI: Oral cancer detection: the importance
of routine screening for prolongation of survival. Postgraduate
Medicine 80(2): 231-236, 1986.
-
Sudbo J, Kildal W, Risberg B, et al.: DNA content as a prognostic marker
in patients with oral leukoplakia. New England Journal of Medicine
344(17): 1270-1278, 2001.
-
Poh CF, Zhang L, Lam WL, et al.: A high frequency of allelic loss in oral
verrucous lesions may explain malignant risk. Laboratory Investigation
81(4): 629-634, 2001.
The routine examination of asymptomatic and symptomatic patients can lead to
detection of earlier stage cancers as well as premalignant lesions. There is
no definitive evidence, however, to show that this screening can reduce
mortality.[1,2]
In Sri Lanka and India, 3 large studies of screening for oral cancer (involving
over 250,000 subjects) have shown that it is possible for primary health care
workers to detect premalignant lesions and early cancers in these populations
at high risk due to habits of tobacco and betel nut chewing and reverse smoking
(placing the lit end of the cigarette in the mouth).[3-5] The general results
of these studies were as follows: 1) 12% to 26% of screened participants had
oral lesions that did not require referral to a specialist; 2) 1.3% to 4.2% of
screened subjects had referable oral mucosal lesions, and of these, 45% to 80%
were correctly referred; 3) the false positive rate ranged from 9% to 29%; and
4) primary health care workers detected a total of 44 new oral cancers.
Compliance rates of these studies varied from 54% to 72%, and poor compliance
following initial screening make feasibility of these types of studies
uncertain. Health education programs only marginally increased compliance
rates. Compliance problems of the Indian and Sri Lankan studies are likewise a
possibility in the United States and other countries, which also have
experienced suboptimal compliance among high-risk tobacco and alcohol users.[6]
Contradictory oral cancer screening recommendations have been issued by the
U.S. Preventive Health Services Task Force (against) and the American Dental
Association (for), illustrating the complexity of the issue.[1] Oral
exfoliative cytology is the most extensively studied screening procedure of
U.S. oral screening programs. Problems encountered with this screening method
include a high proportion of false-negative examinations and poor voluntary
participation by the highest-risk individuals (heavy tobacco and alcohol
users).
References:
- Screening for oral cancer. In: Fisher M, Eckhart C, eds.: Guide to
Clinical Preventive Services: an Assessment of the Effectiveness of 169
Interventions. Report of the U.S. Preventive Services Task Force.
Baltimore, Md: Williams & Wilkins, 1989, pp 91-94.
-
Antunes JP, Biazevic MH, deAraujo ME, et al.: Trends and spatial
distribution of oral cancer mortality in Sao Paulo, Brazil. Oral
Oncology 37: 345-350, 2001.
-
Warnakulasuriya KA, Nanayakkara BG: Reproducibility of an oral cancer and
precancer detection program using a primary health care model in Sri
Lanka. Cancer Detection and Prevention 15(5): 331-334, 1991.
-
Mehta FS, Gupta PC, Bhonsle RB, et al.: Detection of oral cancer using
basic health workers in an area of high oral cancer incidence in India.
Cancer Detection and Prevention 9(3-4): 219-225, 1986.
-
Warnakulasuriya KA, Ekanayake AN, Sivayoham S, et al.: Utilization of
primary health care workers for early detection of oral cancer and
precancer cases in Sri Lanka. Bulletin of the World Health Organization
62(2): 243-250, 1984.
-
Prout MN, Sidari JN, Witzburg RA, et al.: Head and neck cancer screening
among 4611 tobacco users older than forty years. Otolaryngology - Head
and Neck Surgery 116(2): 201-208, 1997.
Date Last Modified: 05/2002
This information from PDQ is reviewed regularly by members of the PDQ
Editorial Boards. If you have specific comments on the content of this
information, direct them to: PDQ Editorial Board, CIPS/NCI, 6116
Executive Boulevard, Suite 3002B, MSC-8321, 20892-8321, fax: 301-480-8105.
* *
The PDQ database also contains listings of clinical trial protocols and
directories of organizations and physicians who treat cancer patients,
but this information is not available through CancerMail. For more
information on accessing PDQ, consult the CancerMail Contents List.
Dr. G. Quade
This page was last modified on Sunday, 02-Nov-2003 15:57:37 CET
Impressum